Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTX | AMGN | GILD | VRTX | REGN |
| Company | Akari Therapeutics ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1850 | 265.72 | 65.50 | 393.52 | 881.72 |
| High | 1.1999 | 271.68 | 66.35 | 398.60 | 887.48 |
| Low | 1.1700 | 265.72 | 64.63 | 393.49 | 875.23 |
| Last | 1.1735 | 269.60 | 65.56 | 398.55 | 882.82 |
| Change | -0.0165 | +0.22 | +0.29 | +0.85 | -7.86 |
| % Change | -1.39% | +0.08% | +0.44% | +0.21% | -0.88% |
| Volume | 2,657 | 355,315 | 4,442,151 | 144,502 | 133,679 |
| 20-Day Average Volume | 16,577 | 2,050,966 | 6,642,376 | 916,140 | 438,101 |
| Previous Close | 1.1900 | 269.38 | 65.27 | 397.70 | 890.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2771 | 269.98 | 68.29 | 401.32 | 918.51 |
| 20-Day Raw Stochastic | 12.43% | 39.35% | 9.78% | 23.96% | 7.61% |
| 20-Day Relative Strength | 29.71% | 45.29% | 29.51% | 43.25% | 32.91% |
| Weighted Alpha | -71.05 | +9.36 | -23.41 | +15.11 | +9.69 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 8% Buy | 8% Sell |
| Previous Opinion | 100% Sell | 72% Sell | 100% Sell | 8% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Sell | 56% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.63% since 04/19/24 | +0.33% since 04/19/24 | -1.93% since 04/19/24 | +1.02% since 04/19/24 | -1.60% since 04/19/24 |
| Low | 1.1300 on 04/23/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 |
| High | 1.2350 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 |
| 1-Month | |||||
| %Chg | -37.75% since 03/26/24 | -4.24% since 03/26/24 | -9.58% since 03/26/24 | -4.82% since 03/26/24 | -8.42% since 03/26/24 |
| Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 1.8999 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -55.72% since 01/26/24 | -13.46% since 01/26/24 | -17.67% since 01/26/24 | -7.41% since 01/26/24 | -6.13% since 01/26/24 |
| Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 2.7400 on 02/02/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -67.40% since 10/26/23 | +0.04% since 10/26/23 | -16.60% since 10/26/23 | +10.25% since 10/26/23 | +11.42% since 10/26/23 |
| Low | 1.0775 on 04/17/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 3.7000 on 10/30/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,429 | 144,488,960 | 81,266,176 | 102,789,152 | 97,762,816 |
| Shares Outstanding, K | 7,924 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -10,010,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -5,680,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 0.96 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/27/22 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/06/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 29.82 | 24.12 |